Large-scale testing (Phase 3)Study completedNCT01485991
What this trial is testing
TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy
Who this might be right for
Hepatitis C
Janssen R&D Ireland 771